Skip to content

Clinical trials

Phase 2 Melanoma trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Melanoma Phase: Phase 2 Country / region: Poland Clear all

22 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20062
20091
20141
20152
20162
20171
20181
20192
20201
20212
20222
20233
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting4
Terminated3
Recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb4
Hoffmann-La Roche3
Amgen2
Merck Sharp & Dohme LLC2
Apexigen America, Inc.1
AstraZeneca1
BioNTech SE1
European Organisation for Research and Treatment of Cancer - EORTC1
Fondazione Melanoma Onlus1
GlaxoSmithKline1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Melanoma22
Carcinoma, Non-Small-Cell Lung4
Carcinoma, Renal Cell3
Skin Neoplasms2
Anus Neoplasms1
Brain Neoplasms1
Breast Neoplasms1
Carcinoma, Small Cell1
Cholangiocarcinoma1
Colorectal Neoplasms1

Trials

Showing 1 to 22 of 22. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.